SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants
PLOS ONE
Authors: Niikura, Takako; Kita, Yoshiko; Abe, Yoichiro
Abstract
Mutations in superoxide dismutase 1 (SOD1) are a major cause of familial amyotrophic lateral sclerosis (ALS), whereby the mutant proteins misfold and aggregate to form intracellular inclusions. We report that both small ubiquitin-like modifier (SUMO) 1 and SUMO2/3 modify ALS-linked SOD1 mutant proteins at lysine 75 in a motoneuronal cell line, the cell type affected in ALS. In these cells, SUMO1 modification occurred on both lysine 75 and lysine 9 of SOD1, and modification of ALS-linked SOD1 mutant proteins by SUMO3, rather than by SUMO1, significantly increased the stability of the proteins and accelerated intracellular aggregate formation. These findings suggest the contribution of sumoylation, particularly by SUMO3, to the protein aggregation process underlying the pathogenesis of ALS.
SUMOylation of Blimp-1 promotes its proteasomal degradation
FEBS LETTERS
Authors: Shimshon, Livnat; Michaeli, Avital; Hadar, Rivka; Nutt, Stephen L.; David, Yael; Navon, Ami; Waisman, Ari; Tirosh, Boaz
Abstract
B lymphocyte induced maturation protein-1 (Blimp-1) is a transcription repressor of the Krueppel-like family. Blimp-1 plays important roles in developmental processes, such as of germ cells and hair follicle stem cells. In B lymphocytes Blimp-1 orchestrates the terminal differentiation into plasma cells. We discovered that Blimp-1 undergoes SUMOylation by SUMO-1. This SUMOylation is modulated by the SUMO protease SENP1. While Blimp-1 is relatively stable in 293T cells, a fusion with SUMO1 rendered it to rapid proteasomal degradation. Increase in SENP1 activity stabilized Blimp-1, while a decrease promoted its degradation. Our data indicate that SUMOylation of Blimp-1 regulates its intracellular stability. Structured summary of protein interactions: Blimp1 physically interacts with SUMO1 by anti tag coimmunoprecipitation (View Interaction 1, 2). SUMO1 physically interacts with Blimp1 by anti tag coimmunoprecipitation (View interaction). (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.